Table 2.

Mean (SD) of SF-36 dimensions in Spanish population and study population during follow-up by gender

	MEN							WOMEN
	BASELINE N = 112		3 MONTHS N = 55		6 MONTHS N = 35		p	BASELINE N = 63		3 MONTHS N = 25		6 MONTHS N = 12		p
	Mean	SD	Mean	SD	Mean	SD		Mean	SD	Mean	SD	Mean	SD
PF	69.4	25.1	74.3	25.7	72.4	25.1	0.45	40.0	29.3	45.4	23.2	37.1	28.5	0.19
RP	62.8	47.9	73.6	41.5	74.3	41.8	0.31	25.0	39.9	62.5	43.3	68.7	46.6	0.02**
BP	64.5	27.6	67.3	25.5	76.5	22.1	0.02**	33.8	20.7	40.9	23.7	41.7	15.9	0.45
GH	62.1	17.5	69.2	17.1	69.6	16.0	0.02*	45.8	22.4	55.6	23.1	53.5	20.9	0.43
VT	69.7	27.1	73.4	26.5	74.7	21.8	0.31	30.8	21.1	58.7	28.3	49.6	31.7	0.003**
SF	86.9	26.2	85.0	29.7	87.5	29.1	0.89	38.5	30.8	80.2	24.7	71.8	31.6	0.006**
RE	88.6	26.7	91.4	28.4	90.5	28.7	0.79	41.7	51.5	47.2	48.1	66.7	49.2	0.42
MH	70.2	17.1	73.3	17.5	72.5	13.8	0.34	49.7	13.4	52.0	25.0	54.0	21.8	0.93
PCS	43.2	11.6	45.8	10.2	46.9	10.6	0.06	33.3	10.8	40.6	7.4	37.5	11.1	0.08
MCS	52.3	7.7	52.5	9.9	52.2	7.5	0.97	35.3	9.4	41.9	14.3	44.4	13.1	0.78

PF: physical functioning; RP: role physical; BP: body pain; GH: general health. PCS: physical component summary; VT: vitality; SF: social functioning; RE: role emotional; MH: mental health; MCS: mental component summary.

ANOVA test with the Bonferroni test for post hoc comparisons in men and Friedman test with the Wilkoxon test for post hoc comparison in women.

p: comparison at three times.

* statistically significant difference between baseline and 3 months

** statistically significant difference between baseline and 6 months.

No significant differences were observed between 3 months and 6 months in any dimension